Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation

2018 ◽  
Vol 549 (1-2) ◽  
pp. 388-396 ◽  
Author(s):  
Shin Jung Park ◽  
Prakash Thapa ◽  
Hye-Jin Seo ◽  
Eun Seok Park ◽  
Seong Hoon Jeong
2007 ◽  
Vol 8 (1) ◽  
pp. E50-E55 ◽  
Author(s):  
Janardhanan Bagyalakshmi ◽  
Ramachandra Purapu Vamsikrishna ◽  
Rajappan Manavalan ◽  
Thengungal Kochupappy Ravi ◽  
Probal Kumar Manna

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S322-S322
Author(s):  
Jennifer Woo ◽  
Ken Hearne ◽  
Andy Kelson ◽  
Luisa Yee ◽  
Cecilia Espadas ◽  
...  

Abstract Background Gallium nitrate citrate exhibits strong antibacterial activity and was recently shown to be safe and efficacious when intravenously administered to cystic fibrosis patients in a Phase 2 clinical study conducted by the University of Washington. We are developing an inhaled formulation of gallium citrate (AR-501), which is being tested in a Phase 1/2a clinical study. The in vitro antimicrobial activities, drug resistance profile, activities in combination with selected antibiotics, and in vivo animal efficacy if the inhaled vs. IV formulation is being presented. Methods MIC tests were performed on strains using the CLSI susceptibility test standards. Resistance testing exposed bacteria to 20 cycles at ranges above and below the MIC level of the drug used.SPF mice (C57BL/6J, 7–9 weeks) were inoculated intranasally with P. aeruginosa under ketamine/xylazine anesthesia. Inhalation of AR-501 used an Aeroneb Solo nebulizer. Gallium levels were determined by elemental analysis using atomic absorption spectroscopy. CFU levels were measured by enumeration of bacterial colonies following serial dilution of tissue homogenates. Results In vitro efficacy: MIC testing demonstrates the efficacy of AR-501 against gram (−), gram (+) and several species of mycobacteria of clinical isolates and the comparative antibacterial response with antibiotics. Resistance testing showed that AR-501 exhibited lower propensity to develop resistance than the antibiotics tested. In vivo efficacy: AR-501 Inhalation also increased the median survival time compared with IV dosing in the murine model. Bacterial clearance was increased when Tobramycin and AR-501 are co-administered. Comparative analysis of AR-501 after IH route demonstrate increased gallium levels in BAL and reduced levels in the kidney in contrast to IV route. Conclusion In vitro studies demonstrate the susceptibility of gram (−), gram (+) and mycobacteria pathogens and the dose range of AR-501 compared with SOC antibiotics. In vivo studies confirm the therapeutic efficacy of AR-501 in bacterial pneumonia by IH delivery and demonstrate that bacterial clearance is enhanced when SOC antibiotics are used in combination with AR-501. Disclosures All authors: No reported disclosures.


2020 ◽  
Vol Volume 15 ◽  
pp. 7601-7613
Author(s):  
Yue Wang ◽  
Shuhang Wang ◽  
Yingju Xu ◽  
Ping Wang ◽  
Sukai Li ◽  
...  

2019 ◽  
Vol 9 (5) ◽  
pp. 67-81
Author(s):  
Gautam D. Mehetre ◽  
A Dubey

The objective of the work is to summarize the applicability, manufacturing possibilities, excipients and the types of floating drug delivery systems and to optimize a floating, mucoadhesive system using Clarithromycin as the drug aiming at the eradication of Helicobacter pylori having desired floating and drug release properties based on preliminary excipient examination. Direct compressed (DC) tablet was chosen as dosage form being a cost-effective technology for pharmaceutical industry requiring fewer procedures. Before the implementation of the pharmaceutical technological aims, analysis of critical factors influencing the manufacture was carried out. Reproducible manufacturing processes are required to achieve suitability and tablets uniformity to achieve the uniform properties of tablets, which could influence experimental parameters. Ishikawa diagram evaluation was created, which is a commonly used graphical method to identify factors resulting in an overall effect on product design and quality imperfection. The aim was to reveal affecting factors on uniformity of DC tablets in order to standardize all possible conditions and adjustments. Critical factors are indicated separately in particular method sections. Keywords: H. pylori, Clarithromycin, Floating Tablets, In Vitro Evaluation, In Vivo Evaluation.


2016 ◽  
Vol 294 ◽  
pp. 93-104 ◽  
Author(s):  
Sarwar Beg ◽  
O.P. Katare ◽  
Sumant Saini ◽  
Babita Garg ◽  
Rajneet Kaur Khurana ◽  
...  

RSC Advances ◽  
2020 ◽  
Vol 10 (71) ◽  
pp. 43629-43639
Author(s):  
Priyanka Rathore ◽  
Alok Mahor ◽  
Surendra Jain ◽  
Anzarul Haque ◽  
Prashant Kesharwani

Insulin-dependent diabetic patients have to count on the administration of painful and discomforting insulin injections.


2015 ◽  
Vol 17 (1) ◽  
Author(s):  
Hale Ünal ◽  
Ivana d’Angelo ◽  
Ester Pagano ◽  
Francesca Borrelli ◽  
Angelo Izzo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document